Jamie L McCall

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 3

Top Topics

Postmenopausal Women

Patient Reported Outcomes

Rheumatoid Arthritis Patients

Top Venues

Pharmacology research & perspectives

Scientific reports

West Virginia University

University of Nebraska Medical Center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

West Virginia University

United States

Post-doctoral Fellow :: Microbiology, Immunology, and Cell Biology

Education History

University of Nebraska Medical Center

United States

PHD :: Cancer Research Graduate Program

University of California Davis

United States

MSC :: Pharmacology and Toxicology

University of California Davis

United States

MSC :: Genetics

Publications

Jamie L McCall, Werner J Geldenhuys, Lisa J Robinson, Michelle R Witt, Peter M Gannett, Björn C G Söderberg, Harry C Blair, Jonathan Soboloff, John B Barnett
Preclinical evaluation of ELP-004 in mice. Pharmacology research & perspectives 12 (4) (2024)
Jamie L McCall, Werner J Geldenhuys, Lisa J Robinson, Michelle R Witt, Peter M Gannett, Björn C G Söderberg, Harry C Blair, Jonathan Soboloff, John B Barnett
Preclinical evaluation of ELP-004 in mice. Pharmacology research & perspectives 12 (4) (2024)
Binita Das, Beth K Neilsen, Kurt W Fisher, Drew Gehring, Youcai Hu, Deanna J Volle, Hyun Seok Kim, Jamie L McCall, David L Kelly, John B MacMillan, Michael A White, Robert E Lewis
A Functional Signature Ontology (FUSION) screen detects an AMPK inhibitor with selective toxicity toward human colon tumor cells. Scientific reports 8 (1) (2018)